Northwestern Medicine investigators have developed first-of-its-kind eyedrops that use synthetic nanoparticles to help the eye regenerate cells that have been damaged by mustard keratopathy, or exposure to mustard gas, and other inflammatory eye diseases, detailed in a recent study published in the journal NPJ Regenerative Medicine.
A new Northwestern Medicine study has identified the molecular mechanisms that cause a commonly prescribed antipsychotic drug to produce harmful side effects similar to Parkinson’s disease symptoms, according to findings published in Molecular Psychiatry.
Using electronic health record data to measure how frequently someone changes their residential address may be an effective tool to screen for patients who may be experiencing homelessness, according to a Northwestern Medicine study published in PLOS One.
Northwestern University scientists have developed the first wearable device for measuring gases emitted from and absorbed by the skin, according to a new study published in Nature.
Northwestern engineers have developed a pacemaker so small that it can fit inside the tip of a syringe and be non-invasively injected into the body.
Opioid testing information was unavailable in half of injury death investigations in the U.S. and in 1 in 10 unintentional overdose death investigations conducted in 2021, according to a recent Northwestern Medicine study published in JAMA.
Investigators are advancing research to support proactive responses in diagnosing and preventing chronic diseases. Across departments, scientists at Feinberg are pursuing new ways of testing to determine a person’s risk of developing chronic conditions.
The use of patient-reported outcomes during cancer treatment improved overall patient care, according to a trial published in Nature Medicine.
A team of experts led by Northwestern Medicine have developed a standardized approach that will improve the measurement of esophageal function to better diagnose upper gastrointestinal disorders, detailed in a recent publication.
Northwestern Medicine scientists have discovered that inhibiting the GATA6 protein in mouse models of colon cancer reduced tumor growth and improved survival, underscoring the potential of a new therapeutic target for colon cancer, according to a recent study published in Science Advances.
Notifications